JPMorgan All Country Research Enhanced Equity ETF sets 0.22% fee, ticker JALL
J.P. Morgan Exchange-Traded Fund Trust filed a 485BPOS and 497K on Thursday, September 3, 2026, listing a 0.22% fee and ticker JALL for JPMorgan All Country Research Enhanced Equity ETF.
An all-country equity series of J.P. Morgan Exchange-Traded Fund Trust, JPMorgan All Country Research Enhanced Equity ETF JALL, is on file with a 0.22% management fee, matching total annual fund operating expenses, and an objective of long-term capital appreciation. The summary prospectus, dated September 14, 2026, says the fund seeks to outperform the MSCI All Country World Index (net total return) while maintaining similar sector and geographic risk, and it names NYSE Arca as the listing exchange.
Under normal circumstances the fund will invest at least 80% of its assets, meaning net assets plus borrowings for investment purposes, in equity securities. J.P. Morgan Investment Management Inc. pays substantially all other fund expenses under the management agreement.
A prior Rule 485(a) amendment had left the ticker and listing exchange blank. Thursday’s Rule 485(b) post-effective amendment and 497K fill both in: JALL on NYSE Arca. JPMorgan already runs Research Enhanced books in international developed stocks through JPMorgan International Research Enhanced Equity ETF JIRE and in U.S. large-caps through JPMorgan U.S. Research Enhanced Large Cap ETF JUSA.
Frequently asked
What does the fund actually invest in?
Under normal circumstances it will put at least 80% of its assets, meaning net assets plus borrowings for investment purposes, in equity securities.
What changed in this filing?
An earlier amendment left the ticker and listing exchange blank, and this one fills in both: JALL on NYSE Arca.
Are there other costs beyond the 0.22%?
The management fee matches total annual fund operating expenses, and the adviser pays substantially all other fund expenses under the management agreement.
How does this fit with JPMorgan's existing funds?
JPMorgan already runs Research Enhanced strategies in international developed stocks through JIRE and in U.S. large-caps through JUSA.